Additionally, tau pathology emerged as a key mediator in the association between amyloid and cerebrovascular burden (WMH) and cognitive impairment, suggesting that tau accumulation may represent a downstream pathway through which these upstream pathologies contribute to cognitive decline. The gene discussed is MAPT; the disease is Cognitive impairment.